Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Hum Genet ; 69(7): 337-343, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38632380

ABSTRACT

BACKGROUND: Distal Xq28 duplication, or int22h1/int22h2-mediated Xq28 duplication syndrome, leads to cognitive impairment, neurobehavioral issues, and facial dysmorphisms. Existing literature has limited information on clinical traits and penetrance. METHODS: We identified cases of distal Xq28 duplication (chrX: 154,126,575-154,709,680, GRCh37/hg19) through a review of clinical records and microarray reports from five centers, encompassing both postnatal and prenatal cases, with no prior family knowledge of the duplication. RESULTS: Our search found 47 cases across 26 families, with duplications ranging from 208 to 935 Kb. In total, 8 out of 26 index cases featured a 200-300 kb partial duplication, mainly from Armenian/Caucasian Jewish backgrounds. Most prenatal cases showed no major fetal ultrasound malformations. Of cases with known inheritance mode (15 out of 26), maternal inheritance was more common (80%). The study identified seven male carriers of the duplication from six unrelated families, indicating partial penetrance in males. CONCLUSION: Our study provides key insights into distal Xq28 duplication. Most prenatal tests showed no major fetal ultrasound issues. Maternal inheritance was common, with unaffected mothers. In the postnatal group, a balanced gender distribution was observed. Among male family members, two fathers had ADHD, one was healthy, and one brother had mild symptoms, indicating partial penetrance in males.


Subject(s)
Chromosome Duplication , Chromosomes, Human, X , Penetrance , Humans , Male , Female , Chromosomes, Human, X/genetics , Chromosome Duplication/genetics , Child , Adult , Child, Preschool , Adolescent , Pedigree , Infant , Phenotype
2.
Reprod Biol Endocrinol ; 20(1): 52, 2022 Mar 17.
Article in English | MEDLINE | ID: mdl-35300691

ABSTRACT

Embryo transfer is a crucial step in IVF cycle, with increasing trend during the last decade of transferring a single embryo, preferably at the blastocyst stage. Despite increasing evidence supporting Day 5 blastocyst-stage transfer, the optimal day of embryo transfer remains controversial. The crucial questions are therefore, whether the mechanisms responsible to embryos arrest are embryo aneuploidy or others, and whether those embryos arrested in-vitro between the cleavage to the blastocyst stage would survive in-vivo if transferred on the cleavage-stage. We therefore aim to explore whether aneuploidy can directly contribute to embryo development to the blastocyst stage. Thirty Day-5 embryos, that their Day-3 blastomere biopsy revealed a single-gene defect, were donated by 10 couples undergoing preimplantation genetic testing treatment at our center. Affected high quality Day-3 embryos were cultured to Day-5, and were classified to those that developed to the blastocyst-stage and those that were arrested. Each embryo underwent whole genome amplification. Eighteen (60%) embryos were arrested, did not develop to the blastocyst stage and 12 (40%) have developed to the blastocyst stage. Nineteen embryos (63.3%) were found to be euploid. Of them, 12 (66.6%) were arrested embryos and 7 (58.3%) were those that developed to the blastocyst-stage. These figures were not statistically different (p = 0.644). Our observation demonstrated that the mechanism responsible to embryos arrest in vitro is not embryo aneuploidy, but rather other, such as culture conditions. If further studies will confirm that Day-5 blastocyst transfer might cause losses of embryos that would have been survived in vivo, cleavage-stage embryo transfer would be the preferred timing. This might reduce the cycle cancellations due to failure of embryo to develop to the blastocyst stage and will provide the best cumulative live birth-rate per started cycle.


Subject(s)
Blastocyst/metabolism , Cleavage Stage, Ovum/metabolism , Embryo, Mammalian/metabolism , Embryonic Development/genetics , Trophoblasts/metabolism , Adult , Aneuploidy , Blastocyst/cytology , Blastomeres/cytology , Blastomeres/metabolism , Cells, Cultured , Cleavage Stage, Ovum/cytology , Comparative Genomic Hybridization/methods , Embryo Transfer , Embryo, Mammalian/cytology , Female , Fertilization in Vitro , Genetic Testing/methods , Humans , Live Birth , Pregnancy , Pregnancy Rate , Trophoblasts/cytology
3.
Reprod Biol Endocrinol ; 18(1): 98, 2020 Oct 06.
Article in English | MEDLINE | ID: mdl-33023576

ABSTRACT

Human embryogenesis frequently coinciding with cell division mistakes contributing to pervasive embryonic aneuploidy/mosaicism. While embryo self-correction was elegantly demonstrated in mouse models, human studies are lacking. Here we are witness to human embryos ability to eliminate/expel abnormal blastomeres as cell debris/fragments. Each blastocyst and its corresponding debris were separated and underwent whole genome amplification. Seven of the 11 pairs of blastocysts and their corresponding cell debris/fragments revealed discordant results. Of the 9 euploid blastocysts, four showed euploid debris, while in the others, the debris were aneuploid. In the remaining pairs, the debris showed additional aneuploidy to those presented by their corresponding blastocyst. The observed ability of human embryos to self-correction doubts many invasive and non-invasive preimplantation testing for aneuploidy at the blastocyst stage, rendering high rate of false positive (discarding "good" embryos) by identifying the cell-free DNA originated from the expelled cell debris, as aneuploidy/mosaic blastocyst.


Subject(s)
Blastocyst , Embryonic Development/physiology , Genetic Diseases, Inborn/embryology , Adult , Biopsy , Blastocyst/metabolism , Blastocyst/pathology , Cell-Derived Microparticles/pathology , Cells, Cultured , Comparative Genomic Hybridization , Embryo Culture Techniques , Embryo Implantation/genetics , Embryonic Development/genetics , Female , Fertilization in Vitro , Genetic Diseases, Inborn/genetics , Genetic Diseases, Inborn/pathology , Genetic Diseases, Inborn/rehabilitation , Genetic Testing , High-Throughput Nucleotide Sequencing , Humans , Male , Preimplantation Diagnosis/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...